2015
DOI: 10.1016/j.micpath.2015.07.012
|View full text |Cite
|
Sign up to set email alerts
|

MAP of F1 and V antigens from Yersinia pestis astride innate and adaptive immune response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…5 Coomassie brilliant blue staining of protein, expressed in different temperatures, IPTG concentrations and culture medium by Taguchi statistical method. Time zero before induction (1,9), test level one (2), two (3), three (4), protein size marker (5), test level four (6), five (7), six (8), seven (10), eight (11) and nine (12) temperature, IPTG concentration, and medium on the V antigen expression. After optimizing the production conditions, the cells were incubated in the cleavage buffer after incubation at 4 °C for 16 h to obtain a protein with a high purity of 90% and a suitable efficiency, as shown in Fig.…”
Section: Purification Of V Antigenmentioning
confidence: 99%
See 1 more Smart Citation
“…5 Coomassie brilliant blue staining of protein, expressed in different temperatures, IPTG concentrations and culture medium by Taguchi statistical method. Time zero before induction (1,9), test level one (2), two (3), three (4), protein size marker (5), test level four (6), five (7), six (8), seven (10), eight (11) and nine (12) temperature, IPTG concentration, and medium on the V antigen expression. After optimizing the production conditions, the cells were incubated in the cleavage buffer after incubation at 4 °C for 16 h to obtain a protein with a high purity of 90% and a suitable efficiency, as shown in Fig.…”
Section: Purification Of V Antigenmentioning
confidence: 99%
“…LcrV is known as the virulence and multifunctional protein. This crucial protein has been shown to act at the level of secretion control by binding to other proteins in order to modulate the host immune response by altering cytokine production [7,8]. Genetic engineering can be used to produce recombinant vaccines using different parts of Yersinia, such as V antigen and F1 [9,10].…”
Section: Introductionmentioning
confidence: 99%